Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Jul 06, 2016 $0.530 $0.550 $0.500 $0.523 324 100
Jul 05, 2016 $0.500 $0.550 $0.490 $0.538 523 200
Jul 01, 2016 $0.450 $0.500 $0.450 $0.490 231 800
Jun 30, 2016 $0.450 $0.470 $0.430 $0.441 231 100
Jun 29, 2016 $0.440 $0.470 $0.435 $0.451 161 500
Jun 28, 2016 $0.440 $0.460 $0.430 $0.440 226 700
Jun 27, 2016 $0.440 $0.450 $0.430 $0.440 195 600
Jun 24, 2016 $0.450 $0.470 $0.430 $0.450 462 000
Jun 23, 2016 $0.460 $0.509 $0.452 $0.479 572 200
Jun 22, 2016 $0.470 $0.490 $0.430 $0.468 203 900
Jun 21, 2016 $0.490 $0.500 $0.460 $0.470 121 400
Jun 20, 2016 $0.500 $0.500 $0.480 $0.490 116 000
Jun 17, 2016 $0.478 $0.492 $0.460 $0.476 80 600
Jun 16, 2016 $0.472 $0.500 $0.468 $0.480 77 800
Jun 15, 2016 $0.480 $0.495 $0.460 $0.495 245 300
Jun 14, 2016 $0.486 $0.495 $0.425 $0.474 393 900
Jun 13, 2016 $0.499 $0.510 $0.490 $0.490 154 900
Jun 10, 2016 $0.510 $0.510 $0.491 $0.491 93 400
Jun 09, 2016 $0.500 $0.505 $0.495 $0.500 160 400
Jun 08, 2016 $0.500 $0.510 $0.491 $0.495 216 100
Jun 07, 2016 $0.510 $0.510 $0.491 $0.502 137 200
Jun 06, 2016 $0.491 $0.520 $0.490 $0.505 288 600
Jun 03, 2016 $0.497 $0.520 $0.470 $0.500 208 900
Jun 02, 2016 $0.530 $0.540 $0.450 $0.485 468 500
Jun 01, 2016 $0.530 $0.560 $0.520 $0.530 157 800
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT